Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Ocrelizumab
Ocrelizumab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
Ocrevus 300 mg concentrate for solution for infusion
Updated
SPC
PIL
No
A
Ocrelizumab
Roche Registration GmbH
Ocrevus 920 mg solution for injection
Updated
SPC
PIL
No
A
Ocrelizumab
Roche Registration GmbH
Cookies
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Product subject to medical prescription which may not be renewed (A)
